TolaSure Topical Gel not checked
BioMendics, LLC · Active Ingredient BM-3103
FollowEvery change as it happens, and a Monday email
Trials
1 active
3 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “TolaSure Topical Gel is applied once-daily to designated treatment areas for up to 4 months (Part 2 End of Study).”In the company’s words, NCT07027345 on ClinicalTrials.gov
- Tested for
- Epidermolysis Bullosa Simplex
- Main trialPhase 2
- “This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (2 years of age and older) diagnosed with localized, intermediate, or severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily application for 2-months. After 2-months, all patients will receive TolaSure Gel to daily apply for an additional 2-months. A remote follow-up visit will occur 2-months after the end of study. Total time…”In the company’s words, NCT07027345 on ClinicalTrials.gov
- Other names
- Active Ingredient BM-3103
Other drugs for Epidermolysis Bullosa Simplex
- AC-201TWi Biotechnology, Inc. · Phase 2/3
- ENERGI-F703Energenesis Biomedical Co., Ltd. · Phase 2
Coming up1
- Jan 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Jan 2027 | A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex | |
| Phase 2Completed | 22 Apr 2020 | Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants | |
| Phase 1Completed | 22 Jun 2023 | Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026